[ad_1]
British Ship’s ‘AZ Vaccine Effective for Seniors’ Announced … France Also Increases Allowable Range to 74 Years
viewer
The quarantine authorities announced that they would make a decision after sufficiently analyzing the vaccination results of each country on whether or not to expand the scope of vaccination against the new coronavirus infection from AstraZeneca (AZ) (Corona 19). Consequently, there is growing interest in whether people aged 65 years and over, who were excluded from priority vaccination due to controversy over the effect of vaccination in the elderly, will also be included in the vaccination target for this vaccine. .
In an online briefing on day 2, Jung Kyung-sil, head of the vaccination management team of the Corona 19 Vaccination Response Advocacy Team, said: “We are constantly collecting relevant evidence” on whether the elderly 65 years or more have received the AstraZeneca vaccine. “After analyzing this and accumulating evidence, it will be decided after receiving expert advice and deliberation from the Specialist Committee on Vaccination” Regarding the specific moment of the decision, he predicted that “we are not reviewing the data by limiting the specific time period “and” if the data like the thesis and the results of clinical trials accumulate enough, I think I can judge it at any time. “
The government initially planned to inoculate the AstraZeneca vaccine to all hospitalized, residents and workers in nursing facilities and nursing hospitals in the first trimester, but for the first time, those over 65, the vaccination was withheld. This is a decision that takes into account the recommendation of the Ministry of Food and Pharmaceutical Safety to carefully decide on the use of the AstraZeneca vaccine for people 65 years of age or older. The Ministry of Food and Drug Safety made this decision because the safety and effectiveness of the AstraZeneca vaccine was proven at the time, but due to the lack of clinical studies in the elderly.
Meanwhile, a recent study in the UK supports the effectiveness of the AstraZeneca vaccine against the elderly. The UK Public Health Administration of England (PHE) surveyed people aged 80 and over who received this vaccine once, and found that hospitalization after 3-4 weeks decreased by 80%, and in people Over 70 years of age, the effect of preventing infection after 4 weeks of vaccination was 60. It was found to be ∼73%. France recognized the efficacy of this vaccine based on the study results and extended the vaccination age to 74 years, and Germany is also reconsidering its policy of “ not recommending vaccination with AstraZeneca to the elderly. ”
“Clinical trials are currently underway in each country and, in some countries, the results of vaccination for the elderly are being published,” said Mr. Jeong. “Not only the results of the US clinical trial, but also the vaccination results of each country are reported as a whole.) I will decide.”
Currently, in Korea, since the 26th of last month, the AstraZeneca vaccine is administered to those under 65 years of age among hospitalized, residents and workers in nursing facilities and nursing hospitals. Pfizer vaccination has started.
/ Inside reporter Park Shin-won [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >
